drugset / Trial / NCT05475171

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

NCT05475171

Phase 2 Suspended 47 enrolled M.D. Anderson Cancer Center MacroGenics · collab
NaSingle-groupOpen-labelTreatment

Summary

To learn if MGD019 can help to control cervical cancer in patients who have yet to receive treatment.

Timeline

Start
2022-12-13
Primary completion
2028-06-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorigerlimab Protein / enzyme biologic Intravenous